Virtus SGA Emerging Markets Equity C (PICEX)
Nasdaq • Currently down 0.04 (-0.57%) in today's trading session
1 member of Congress has disclosed 2 trades in Virtus SGA Emerging Markets Equity C (PICEX) via STOCK Act filings. The most recent disclosure was a purchase by Brian Babin on 5 November 2018. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).
Virtus SGA Emerging Markets Equity C is currently trading at $6.98, positioned at 36% of its 52-week range ($6.46 – $7.89).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Virtus SGA Emerging Markets Equity C Price History and Technical Analysis
Congressional Trading Activity for PICEX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about PICEX
- Which members of Congress have traded PICEX?
- 1 member of Congress has disclosed 2 trade in Virtus SGA Emerging Markets Equity C (PICEX) under the STOCK Act: Brian Babin.
- When was PICEX most recently disclosed by Congress?
- The most recent PICEX disclosure was a purchase by Brian Babin on 5 November 2018.
- What is the total disclosed congressional trading volume for PICEX?
- Members of Congress have disclosed approximately $16K in PICEX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in PICEX?
- This PICEX page updates as soon as new STOCK Act disclosures are filed for Virtus SGA Emerging Markets Equity C. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track PICEX in Congress
See when politicians buy or sell this stock